Placebo by Proxy in Neonatal Randomized Controlled Trials: Does It Matter?

Placebo by Proxy in Neonatal Randomized Controlled Trials: Does It Matter?

Placebo effects emerging from the expectations of relatives, also known as placebo by proxy, have seldom been explored. The aim of this study was to investigate whether in a randomized controlled trial (RCT) there is a clinically relevant difference in long-term outcome between very preterm infants...

Full description

Bibliographic Details
Main Authors: Tiziana L. Burkart, Andrea Kraus, Brigitte Koller, Giancarlo Natalucci, Beatrice Latal, Jean-Claude Fauchère, Hans Ulrich Bucher, Christoph M. Rüegger, for the Swiss EPO Neuroprotection Trial Group
Format: Article
Language:English
Published: MDPI AG 2017-05-01
Series:Children
Subjects:
preterm infants
placebo by proxy
long-term outcome
randomized controlled trial
Online Access:http://www.mdpi.com/2227-9067/4/6/43

Internet

http://www.mdpi.com/2227-9067/4/6/43

Similar Items